1. What Is the Point of Care Testing Market?
The Point of Care Testing Market covers diagnostic tests performed near the patient at the bedside, in physician offices, urgent care centers, pharmacies, and home settings, delivering actionable results without centralized laboratory infrastructure. Clinicians, nurses, and patients deploy immunoassay-based rapid tests, handheld chemistry analyzers, portable molecular platforms, and connected biosensor devices for timely clinical decision-making. The market spans infectious disease testing, metabolic monitoring, cardiac biomarkers, and coagulation assessment conducted outside of central laboratories.
2. Point of Care Testing Market Size & Forecast
3. Emerging Technologies
- Smartphone-integrated POC readers converting consumer smartphone cameras and processors into quantitative immunoassay readers for decentralized testing without dedicated reader hardware.
- Microfluidic sample preparation chips enabling whole-blood-to-result testing without centrifugation or manual processing for truly operator-independent POC use.
- AI-powered POC quality assurance systems automatically detecting invalid test results and operator errors before clinical reporting.
- Wearable continuous POC biosensors providing ambulatory metabolic and biomarker monitoring beyond episodic testing.
Similar technologies are also transforming adjacent markets. Learn more in our Continuous Glucose Monitoring Market.
4. Key Market Opportunity
Pharmacy-based POC program expansion represents the largest new channel growth opportunity. Emerging market POC access investment for infectious disease and maternal health is the largest humanitarian and commercial volume opportunity. Home-based POC for chronic disease management is the fastest-growing consumer segment.
5. Top Companies in the Point of Care Testing Market
The following organisations hold leading positions in the Point of Care Testing Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott Laboratories
- Roche Diagnostics
- bioMerieux
- Siemens Healthineers
- Danaher
- Becton Dickinson
- QuidelOrtho
- Chembio Diagnostics
- SD Biosensor
- Bosch Healthcare
6. Market Segmentation
The Point of Care Testing Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | Lateral Flow Immunoassay Microfluidic Cartridge Handheld Electrochemical Sensor Miniaturized PCR Connected Biosensor |
| By Application | Infectious Disease POC Glucose and Metabolic POC Cardiac Biomarker POC Coagulation POC Women's Health POC |
| By End-User | Hospital Bedside and Emergency Physician Office Laboratory Urgent Care and Pharmacy Home and Consumer Remote and Resource-Limited Settings |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Point of Care Testing Market trajectory over the forecast period:
Decentralized testing is accelerating as healthcare systems restructure care delivery toward ambulatory, urgent care, and home settings where central laboratory turnaround time creates unacceptable delays.The pandemic validated POC testing at non-traditional sites and sustained demand beyond infectious disease into metabolic and cardiac applications. Health systems are systematically investing in POC programs to support clinical decision-making at the point of need rather than the point of testing.
Connected POC devices are creating a data integration layer enabling POC results to flow directly into electronic health records and clinical decision support systems.Bluetooth and cellular connectivity within POC devices eliminates manual transcription errors while enabling real-time result surveillance. Abbott Alere i, Roche cobas Liat, and platform-level connectivity frameworks are establishing connected POC as the expected standard replacing standalone device paradigms.
Pharmacy-based POC testing is expanding access as retail pharmacy chains in the United States and Europe establish clinical testing services.CVS MinuteClinic, Walgreens, and Boots deploy POC infectious disease, metabolic, and wellness testing within pharmacy retail environments. The pharmacy channel expansion is creating a large new POC testing distribution network beyond traditional clinical settings.
For related market intelligence, see the Rapid Antigen Tests Market.
8. Segmental Analysis
By technology, the lateral flow immunoassay segment dominated the Point of Care Testing Market in 2025, as lateral flow-based rapid tests representing the simplest and most widely deployed POC technology sustain the largest test volume across infectious disease and consumer POC applications globally.
By end-user, the pharmacy and urgent care segment is projected to register the highest growth rate through 2034, as retail pharmacy clinical testing program expansion is creating a large new POC testing distribution channel growing faster than traditional clinical POC settings.
9. Regional Analysis
Regional demand patterns across the Point of Care Testing Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Point of Care Testing Market in 2025, accounting for around 42 percent of global revenue. The United States ambulatory care infrastructure combined with high pharmacy-based testing adoption drives the world's largest POC testing market. Abbott, Roche, and QuidelOrtho generate dominant U.S. POC revenue across hospital, pharmacy, and home settings. Moreover, U.S. regulatory frameworks enabling pharmacy clinical testing have expanded the addressable POC channel substantially.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR in the Point of Care Testing Market through 2034. The region's large underserved population combined with expanding healthcare access is driving substantial POC testing adoption where central laboratory infrastructure is limited. Chinese POC market expansion through domestic manufacturer development at SD Biosensor and international brand adoption creates substantial regional demand. Indian and Southeast Asian public health programs are driving systematic POC infectious disease testing adoption.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Point of Care Testing Market was valued at USD 8.47 Bn in 2025 and is projected to reach USD 19.02 Bn by 2034, growing at a CAGR of 9.4% over the 2026–2034 forecast period.
The Point of Care Testing Market is projected to grow at a CAGR of 9.4% from 2026 to 2034.
North America dominated the Point of Care Testing Market in 2025, accounting for around 42 percent of global revenue.
The leading companies in the Point of Care Testing Market include Abbott Laboratories, Roche Diagnostics, bioMerieux, Siemens Healthineers, Danaher, Becton Dickinson, QuidelOrtho, Chembio Diagnostics, SD Biosensor, Bosch Healthcare.
Decentralized testing is accelerating as healthcare systems restructure care delivery toward ambulatory, urgent care, and home settings where central laboratory turnaround time creates unacceptable delays.
By technology, the lateral flow immunoassay segment dominated the Point of Care Testing Market in 2025, as lateral flow-based rapid tests representing the simplest and most widely deployed POC technology sustain the largest test volume across infectious disease and consumer POC applications globally.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 3 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 3 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 3 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.